Rifamycin antibiotic

This page covers all Rifamycin antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial RNA polymerase, Bacterial RNA polymerase β-subunit, Bacterial RNA polymerase (RNAP).

Targets

Bacterial RNA polymerase · Bacterial RNA polymerase β-subunit · Bacterial RNA polymerase (RNAP) · Bacterial RNA polymerase (mycobacterial) · RNA polymerase

Marketed (11)

• Rifampicin Capsules · Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Infectious Disease
  Rifampicin inhibits bacterial RNA polymerase, preventing transcription and blocking bacterial protein synthesis.
• Rifampicin alone · Miguel Santín · Infectious Disease
  Rifampicin inhibits bacterial RNA polymerase, preventing transcription and blocking bacterial protein synthesis.
• Rifabutin/rifampin · The University of Texas Health Science Center at Tyler · Infectious Disease
  Rifabutin and rifampin are rifamycin antibiotics that inhibit bacterial RNA polymerase, preventing transcription and killing mycobacteria and other bacteria.
• rifampin IV · University of California, San Francisco · Infectious Disease
  Rifampin inhibits bacterial RNA polymerase, preventing transcription and blocking bacterial protein synthesis.
• Rifampicin (R) · University College, London · Infectious Disease
  Rifampicin inhibits bacterial RNA polymerase, preventing transcription and blocking bacterial protein synthesis.
• Rifamycin-containing regimen · National Taiwan University Hospital · Infectious Disease
  Rifamycins inhibit bacterial RNA polymerase, preventing transcription and blocking bacterial protein synthesis.
• Rifampin (RIF) · National Institute of Allergy and Infectious Diseases (NIAID) · Infectious Disease
  Rifampin inhibits bacterial RNA polymerase, blocking transcription and preventing bacterial RNA synthesis.
• Rifampicin (RIF) · National Institute of Allergy and Infectious Diseases (NIAID) · Infectious Disease
  Rifampicin inhibits bacterial RNA polymerase, preventing transcription and blocking bacterial protein synthesis.
• RIF · South China Children's Leukemia Group · Oncology (supportive care) / Infectious Disease
  RIF is a rifampicin-based antimicrobial agent used in pediatric leukemia supportive care to prevent or treat infections.
• Rifaximin (drug) · Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji · Gastroenterology / Infectious Disease
  Rifaximin is a non-absorbed antibiotic that inhibits bacterial RNA polymerase to reduce pathogenic gut bacteria.
• Rifaximin oral tablet · Yokohama City University · Gastroenterology / Infectious Disease
  Rifaximin is a non-absorbed antibiotic that inhibits bacterial RNA polymerase to reduce pathogenic gut bacteria.

Phase 3 pipeline (8)

• High-dose rifampicin · Seoul National University Hospital · Infectious Disease
  High-dose rifampicin inhibits bacterial RNA polymerase to suppress mycobacterial growth and modulate immune responses.
• rifampin, randomized, open label · National Taiwan University Hospital · Infectious Disease
  Rifampin inhibits bacterial RNA polymerase, preventing transcription and blocking bacterial protein synthesis.
• Rifasutenizol capsules · TenNor Therapeutics (Suzhou) Limited · Infectious Disease
  Rifasutenizol is a rifamycin-class antibiotic that inhibits bacterial RNA polymerase to prevent transcription and translation in mycobacteria.
• open-label rifaximin · Bausch Health Americas, Inc. · Gastroenterology
  Rifaximin works by inhibiting bacterial RNA synthesis, thereby reducing bacterial load in the gut.
• SDR-PEP Rifampicin · Institute of Tropical Medicine, Belgium · Infectious Disease
  SDR-PEP Rifampicin is a sustained-release formulation of rifampicin that inhibits bacterial RNA polymerase to suppress mycobacterial protein synthesis.
• BE-PEP Rifampicin · Institute of Tropical Medicine, Belgium · Infectious Disease
  BE-PEP Rifampicin is a rifampicin-based formulation designed to improve bioavailability and reduce dosing frequency for tuberculosis treatment.
• Rifaximin SSD · Bausch Health Americas, Inc. · Gastroenterology
  Rifaximin SSD is a non-absorbed antibiotic that inhibits bacterial RNA polymerase to reduce pathogenic gut bacteria.
• Rifapentine (RPT) · Walter K. Kraft · Infectious Disease
  Rifapentine inhibits bacterial RNA polymerase, preventing transcription and killing or stopping the growth of mycobacteria.